Login / Signup

Patient blood management guideline for adults with critical bleeding.

Biswadev MitraMargaret JorgensenMichael Charles ReadeAnastazia KeeganAnthony HolleyShannon FarmerNichole HarveyJames WinearlsMichael ParrCraig J Frenchnull null
Published in: The Medical journal of Australia (2024)
The new guideline recommends MHPs be established as standard of care in all institutions managing patients with critical bleeding. In addition to routine physiological markers, the new guideline recommends temperature, biochemistry and coagulation profiles be measured early and frequently, providing parameters that define critical derangements. Ratio-based MHPs should include no fewer than four units of fresh frozen plasma and one adult unit of platelets for every eight units of red blood cells. In the setting of trauma and obstetric haemorrhage, administration of tranexamic acid within three hours of bleeding onset is recommended. The use of recombinant activated factor VII (rFVIIa) is not recommended. There was insufficient evidence to make recommendations on the use of viscoelastic haemostatic assays or cell salvage as part of MHPs.
Keyphrases
  • red blood cell
  • atrial fibrillation
  • healthcare
  • clinical practice
  • palliative care
  • case report
  • high throughput
  • cell therapy
  • quality improvement
  • young adults
  • mesenchymal stem cells
  • affordable care act
  • single molecule